Corvidia Therapeutics Patents – Insights & Stats (Updated 2023)

Corvidia Therapeutics has a total of 27 patents globally, out of which no patents have been granted. Of these 27 patents, more than 66% patents are active. Israel is where Corvidia Therapeutics has filed the maximum number of patents, followed by Korea (South) and Hong Kong (S.A.R.). Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Corvidia Therapeutics.

Corvidia Therapeutics was founded in the year 2014. The Company discovers, develops and commercializes precision therapeutics for the treatment of diseases.

Do read about some of the most popular patents of Corvidia Therapeutics which have been covered by us in this article and also you can find Corvidia Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Corvidia Therapeutics patent portfolio.

How many patents does Corvidia Therapeutics have?

Corvidia Therapeutics has a total of 27 patents globally. These patents belong to 5 unique patent families. Out of 27 patents, 18 patents are active.

How Many Patents did Corvidia Therapeutics File Every Year?

Corvidia Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantCorvidia Therapeutics Applications FiledCorvidia Therapeutics Patents Granted
20211
20207
20199
201810

How many Corvidia Therapeutics patents are Alive/Dead?

Corvidia Therapeutics Patent Portfolio

How Many Patents did Corvidia Therapeutics File in Different Countries?

Corvidia Therapeutics Worldwide Patent Filing

Countries in which Corvidia Therapeutics Filed Patents

CountryPatents
Israel4
Korea (South)3
Hong Kong (S.A.R.)3
India3
Taiwan2
Brazil2
Japan2
Viet Nam1
Colombia1
Chile1
Malaysia1

Where are Research Centres of Corvidia Therapeutics Patents Located?

R&D Centers of Corvidia Therapeutics

List of Corvidia Therapeutics Patents

Corvidia Therapeutics PatentsTitle
HK40031127AMethods For Treating Il-6 Mediated Inflammation Without Immunosuppression
HK40019119ATreatment Of Diuretic Resistance
HK40017993AApoc-Ii Mimetic Peptides
IL281274ATreatment Of Diuretic Resistance
IL279831AApoc-Ii Mimetic Peptides
IL275696AMethods For Treating Il-6 Mediated Inflammation Without Immunosuppression
IL268093AApoc-Ii Mimetic Peptides
TW202130366APrecision Treatment Of Heart Failure And Cardiorenal Syndrome
CL202001790A1Methods To Treat Il-6 Mediated Inflammation Without Immunosuppression
BR112020013519A2Method For Treatment Of Inflammation.
VN74290AIl-6 Antagonists For The Treatment Of Il-6-Mediated Inflammation Without Immune Suppression
CO20200009510A2Methods To Treat Il-6 Mediated Inflammation Without Immunosuppression
BR112019014707A2Isolated Apoc-Ii Mimetic Peptide, Pharmaceutical Composition, And, Methods For Treatment Hypertriglyceridemia And For Manufacturing The Peptide.
KR1020200012823ATreatment Of Diuretic Resistance
IN201917034989ATreatment Of Diuretic Resistance
KR1020190121305AApoc-Ii Mimetic Peptides
IN201917032726AApoc-Ii Mimetic Peptides
MYPI2020003508A0Methods For Treating Il-6 Mediated Inflammation Without Immunosuppression
WO2020223565A1Anti-Il-6 Antibody Formulation
WO2018136803A8Apoc-Ii Mimetic Peptides
WO2019136312A1Methods For Treating Il-6 Mediated Inflammation Without Immunosuppression
WO2018144773A1Treatment Of Diuretic Resistance
JP2020506190A5Treatment Of Diuretic Resistance
JP2021509668AMethods Of Treating Il-6-Mediated Inflammation Without Immunosuppression
TW202130652AApoc-Ii Mimetic Peptides
KR1020200116089AMethods For Treating Il-6-Mediated Inflammation Without Immunosuppression
IN202017031759AMethods For Treating Il-6 Mediated Inflammation Without Immunosuppression

What are Corvidia Therapeutics key innovation segments?

What Technologies are Covered by Corvidia Therapeutics?

The chart below distributes patents filed by Corvidia Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Corvidia Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Corvidia Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Corvidia Therapeutics?

Related Articles

Alphapharm Patents – Insights & Stats (Updated 2024)

Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be

Read More »

Complexa Patents – Insights & Stats (Updated 2024)

Complexa has a total of 77 patents globally, out of which 16 have been granted. Of these 77 patents, more than 22% patents are active. The United States of America is where Complexa has filed the maximum number of patents, followed by Japan. Parallelly, United States of America seems to

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.